Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XBIT

XBiotech Inc

May 11 • 04:00PM ET

2.47

+0.01 0.41 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ZURA SABS XLO CABA IMUX

| Held by: VXF BSVO IWC AVSC AVUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.49	Insider Own	36.61%	Shs Outstand	30.49M	Perf Week	-3.14%
Market Cap	75.30M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	19.32M	Perf Month	6.01%
Enterprise Value	-50.25M	PEG	-	EPS next Q	-	Inst Own	7.49%	Short Float	0.77%	Perf Quarter	6.93%
Income	-45.54M	P/S	-	EPS this Y	-	Inst Trans	-8.33%	Short Ratio	4.54	Perf Half Y	3.35%
Sales	0.00M	P/B	0.54	EPS next Y	-	ROA	-26.07%	Short Interest	0.15M	Perf YTD	3.35%
Book/sh	4.60	P/C	0.60	EPS next 5Y	-	ROE	-28.23%	52W High	3.61 -31.58%	Perf Year	-10.83%
Cash/sh	4.12	P/FCF	-	EPS past 3/5Y	-11.39% -32.63%	ROIC	-32.45%	52W Low	2.09 18.18%	Perf 3Y	-26.49%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	1.68% 3.28%	Perf 5Y	-83.64%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-18.10%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-77.73%
Dividend Ex-Date	Jul 15, 2021	Quick Ratio	16.01	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.17	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	16.01	EPS Q/Q	-155.90%	SMA20	-1.62%	Beta	0.87	Target Price	28.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	2.82%	Rel Volume	1.23	Prev Close	2.46
Employees	85	LT Debt/Eq	0.00	Earnings	-	SMA200	-3.64%	Avg Volume	32.71K	Price	2.47
IPO	Apr 15, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	40,150	Change	0.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)